definition of glp-1 Agonists: A Comprehensive Overview GLP-1 Formula

Description

This blog is part of an ongoing series on A Brave New World: Therapeutic Area Deep Dives

The number of Americans taking a GLP-1 for weight management has increased nearly 600% over the past 6 years (FAIR Health, May 2025), making support products for those consumers more in-demand than ever

Our GLP-1 Medical Weight Loss Program harnesses the power of Mounjaro, Wegovy or Zepbound to promote sustainable weight loss.

The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period

Los agonistas de los receptores GLP-1 y GIP son tratamientos innovadores desarrollados inicialmente para la diabetes, pero que ahora se utilizan para tratar la obesidad